TBEV Stock | News | Quote | Stock Forum | Wednesday, February

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Indices: Mixed Signals as Investors Shift Focus US equity index futures remain steady after a recent market rotation. While the S&P 500 ended flat, the Nasdaq 100 experienced a slight decline as investors adjusted their portfolios, particularly moving away from high-profile technology stocks. However, the Dow showed resilience, bolstered by robust performance in defense...

Embarking on a New Anime Adventure Kagurabachi is the latest sensation gearing up to hit the anime airwaves, and boy, does it come with quite the pedigree. This isn't just another blip on the Weekly Shonen Jump lineup. Nope, it's a full-throttle affair mean't to slash its way into our hearts—and maybe wallets, but more on that later. The Cast That Packs a Punch Miku...

Introducing Lefty™: An Innovative Drink for Left-Handed Athletes Finally, there's a sports drink that acknowledges the unique challenges faced by left-handed individuals in a world designed for right-handers. Pickle Juice® has unveiled Lefty™, a revolutionary beverage tailored to left-handed athletes, addressing issues from awkward packaging to the frustration of...

Flat Footed LLC's Concerns About Grifols' Governance Flat Footed LLC, a notable investment manager, is making headlines for urging Grifols, S.A. to reconsider its governance strategy. Holding a significant 4.64% stake in the company, Flat Footed aims to enhance transparency and align the interests of shareholders. Letter to the Board of Directors Recently, Flat Footed LLC...

Piramal Pharma Limited Reports Strong Q2 and H1 FY25 Results Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a prominent global pharmaceuticals and wellness entity, has outlined its standalone and consolidated results for the Second Quarter (Q2) and Half Year (H1) concluded in September 2024. The company has demonstrated impressive growth in key financial metrics,...